Progress in personalizing chemotherapy for bladder cancer - Wikidata - awgldk - TriplyDB

Progress in personalizing chemotherapy for bladder cancer

Progress in personalizing chemotherapy for bladder cancer

http://www.wikidata.org/entity/Q35779460

about

Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1 miR-193a-3p regulates the multi-drug resistance of bladder cancer by targeting the LOXL4 gene and the oxidative stress pathway.Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters.Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging.The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression Contemporary management of muscle-invasive bladder cancer Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches.Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?

P2860

Q33638575-E1F7271E-395C-4D53-8657-46344356F583 Q34355302-11239609-974C-4ED0-A4B2-95BDECBA540B Q34982947-BD2AE856-537C-4939-A49F-E16586E32A7A Q35078389-484456C9-CB19-4B18-BFBD-EE4475D50999 Q35832954-74C62675-411B-4848-9A6E-FDA527D95FF8 Q35966228-C0933FF0-1E43-4005-B2A1-2E3DF2A4F647 Q36389716-22F59072-1140-47D3-A21E-B7DBE1A84388 Q36589753-B8A7C7B7-7867-4057-B5CE-04F2CB259C82 Q37737916-3FDC86F8-5DAA-429B-8380-7F53114B54CE Q44138102-5056ACA1-E3B0-40CD-8FA0-AAFFF6F5516A

P2860

Progress in personalizing chemotherapy for bladder cancer

http://www.wikidata.org/entity/Q35779460

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Progress in personalizing chemotherapy for bladder cancer

@ast

Progress in personalizing chemotherapy for bladder cancer

@en

type

label

Progress in personalizing chemotherapy for bladder cancer

@ast

Progress in personalizing chemotherapy for bladder cancer

@en

prefLabel

Progress in personalizing chemotherapy for bladder cancer

@ast

Progress in personalizing chemotherapy for bladder cancer

@en

P1433

Q35779460-958A2C95-D4AA-4A6F-8962-CF6AD9F13D85

P1476

Q35779460-0192F253-52FD-4A1B-9F1A-ED5EC58069CC

P2093

Q35779460-68478B1B-25E8-4FB8-986A-814C2655C4A0

Q35779460-96540E38-80F6-4820-B8A5-1BA6172F5428

Q35779460-C0191E4E-62EF-478D-A15F-5C9830454EF3

P2860

Q35779460-09B9CBD0-BBFF-48BA-8AD0-4CF1F3A9F5EC

Q35779460-0B0AC1BF-0167-4F04-B2E2-2C608A35E346

Q35779460-12A68452-5281-4ACE-A14C-A20B667FAC87

Q35779460-161AED76-4FDC-41AF-8742-912E213D22C0

Q35779460-17C3F6E4-89C9-45B5-B243-2DDB0111EABC

Q35779460-1B3E52E4-AAD5-4CD6-B448-60C646E0C182

Q35779460-20111325-2710-41B4-9586-FA0F46C9390F

Q35779460-22320F9C-F7E3-4997-BD79-F11B97033EDD

Q35779460-24904440-1294-4F11-BFC6-51ED04A25729

Q35779460-2865F5CA-7A0A-4C02-9E38-18A2D4CC86B3

P304

Q35779460-E64D63FA-9F38-423E-B168-B13C49D8FAB1

P31

Q35779460-80E3ECA0-46E3-4686-98A1-264875F55DCC

P356

Q35779460-A4AF2D29-3F16-404B-83EA-0346627AA291

P478

Q35779460-9A15BA74-A884-4648-852C-CDE194229516

P577

Q35779460-EDCA8A1A-5A3E-44B8-99EA-908725C2C7C2

P5875

Q35779460-131FF287-8703-4A83-9605-767BCA86E17C

P698

Q35779460-F772A39D-F90A-470A-9082-846938FE2764

P921

Q35779460-94DB89A1-3078-4168-A1CA-8E797882A9A3

P932

Q35779460-0FAA0324-F619-4DB5-ACF3-FF03111BA34B

P356

P1433

Advances in Urology

P1476

Progress in personalizing chemotherapy for bladder cancer

@en

P2093

Chong-Xian Pan

http://www.w3.org/2001/XMLSchema#string

James S Chang

http://www.w3.org/2001/XMLSchema#string

Primo N Lara

http://www.w3.org/2001/XMLSchema#string

P2860

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

Purification and characterization of the XPF-ERCC1 complex of human DNA repair excision nuclease

Cancer statistics, 2010

Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

The genetics of the p53 pathway, apoptosis and cancer therapy.

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

Cellular processing of platinum anticancer drugs

P304

364919

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/364919

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221686415

http://www.w3.org/2001/XMLSchema#string

P698

22400017

http://www.w3.org/2001/XMLSchema#string

P921

P932

3287014

http://www.w3.org/2001/XMLSchema#string